Increased GAPDH expression has been reported in human cancers from prostate, lung and cervix (Kim et al. 1998; Rondinelli et al. 1997; Tokunaga et al. 1987), as well as in MCF-7 breast cancer cells treated with estradiol (Révillion et al. 2000). Here, GAPDH is linked to breast cancer.